Skip to Content

B683 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint B683 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B683

Rabeprazole sodium delayed-release 20 mg B683

Rabeprazole Sodium Delayed-Release

Imprint
B683
Strength
20 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0683
Inactive Ingredients
diacetylated monoglycerides, hypromellose phthalate (31% phthalate, 40 cst), magnesium oxide, magnesium stearate, mannitol, magnesium silicate, titanium dioxide, ferric oxide yellow, ammonia, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.